These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9076837)

  • 1. Predicting the clinical efficacy of antibiotics: toward definitive criteria.
    Scaglione F
    Pediatr Infect Dis J; 1997 Mar; 16(3 Suppl):S56-9. PubMed ID: 9076837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdialysis studies of the distribution of antibiotics into chinchilla middle ear fluid.
    Sawchuk RJ; Cheung BW; Ji P; Cartier LL
    Pharmacotherapy; 2005 Dec; 25(12 Pt 2):140S-145S. PubMed ID: 16305284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of antibiotics in children.
    Toyonaga Y
    Acta Paediatr Jpn; 1997 Feb; 39(1):114-23. PubMed ID: 9124043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the efficacy of antimicrobial agents in respiratory infections--is tissue concentration a valid measure?
    Bergogne-Bérézin E
    J Antimicrob Chemother; 1995 Mar; 35(3):363-71. PubMed ID: 7782252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of newer macrolides.
    Nightingale CH
    Pediatr Infect Dis J; 1997 Apr; 16(4):438-43. PubMed ID: 9109156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting antibacterial response from pharmacodynamic and pharmacokinetic profiles.
    Nicolau DP
    Infection; 2001 Dec; 29 Suppl 2():11-5. PubMed ID: 11785851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new antibiotics.
    Birnbaumer D; Fernández-Frackelton M
    Emerg Med Clin North Am; 2000 Nov; 18(4):671-708. PubMed ID: 11130933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring of antibiotic treatment of patient with a severe bacterial infection].
    Aubert G; Carricajo A
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS; Paladino JA; Schentag JJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A predictive parameter of antibacterial efficacy in vivo, based on efficacy in vitro and pharmacokinetics.
    Mattie H
    Scand J Infect Dis Suppl; 1990; 74():133-6. PubMed ID: 2129065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial agents in pediatrics.
    LiPuma JJ; Stull TL
    Infect Dis Clin North Am; 1995 Sep; 9(3):561-74. PubMed ID: 7490433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary issues in the management of pediatric infections.
    Helwig H
    Pediatr Infect Dis J; 1997 Mar; 16(3 Suppl):S39-42. PubMed ID: 9076834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia.
    Aitken SL; Altshuler J; Guervil DJ; Hirsch EB; Ostrosky-Zeichner LL; Ericsson CD; Tam VH
    Int J Antimicrob Agents; 2015 May; 45(5):541-4. PubMed ID: 25665726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacteriological, pharmacokinetic and clinical evaluations of cefpirome sulfate in the pediatric field. Pediatric Study Group of Cefpirome].
    Fujii R; Abe T; Meguro H; Tajima T; Nakazawa S; Sato H; Hirama Y; Narita A; Matsumoto K; Nakazawa S
    Jpn J Antibiot; 1991 Jan; 44(1):84-109. PubMed ID: 2041150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephem antibiotics: wise use today preserves cure for tomorrow.
    Parker S; Mitchell M; Child J
    Pediatr Rev; 2013 Nov; 34(11):510-23; quiz 523-4. PubMed ID: 24187143
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
    Segreti J; Jones RN; Bertino JS
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):3-11. PubMed ID: 21999341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of beta-lactam antibiotics in infections--an overview.
    Quintiliani R
    Scand J Infect Dis Suppl; 1984; 42():99-109. PubMed ID: 6597565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.
    Nomura K; Morikawa N; Ikawa K; Ikeda K; Fujimoto Y; Shimizu D; Taniguchi K; Shimura K; Kanbayashi Y; Komori T; Matsumoto Y; Fujita N; Shimazaki C; Taniwaki M
    J Antimicrob Chemother; 2008 Apr; 61(4):892-900. PubMed ID: 18276604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.